These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9780536)

  • 1. Generalizing costs from trials. Analyzing center selection bias in a breast screening trial.
    Johnston K; Gerard K; Brown J
    Int J Technol Assess Health Care; 1998; 14(3):494-504. PubMed ID: 9780536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The economic evaluation of the early diagnosis of breast carcinoma: a review of the literature].
    Vanara F
    Epidemiol Prev; 1992 Dec; 14(53):22-31. PubMed ID: 1341665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for breast cancer.
    O'Doherty AJ; Donaghy P
    Lancet; 1990 Feb; 335(8684):296. PubMed ID: 1967755
    [No Abstract]   [Full Text] [Related]  

  • 4. Counting costs of screening.
    Lyall J
    Health Serv J; 1986 Nov; 96(5026):1506. PubMed ID: 10279720
    [No Abstract]   [Full Text] [Related]  

  • 5. Breast and cervical carcinoma screening practices among women in rural and nonrural areas of the United States, 1998-1999.
    Coughlin SS; Thompson TD; Hall HI; Logan P; Uhler RJ
    Cancer; 2002 Jun; 94(11):2801-12. PubMed ID: 12115366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for breast cancer.
    Lancet; 1982 May; 1(8281):1103-4. PubMed ID: 6122895
    [No Abstract]   [Full Text] [Related]  

  • 7. Costs of breast cancer and the cost-effectiveness of breast cancer screening.
    Elixhauser A
    Int J Technol Assess Health Care; 1991; 7(4):604-15. PubMed ID: 1778705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening, detection, and diagnosis of breast cancer.
    Miller AB; Bulbrook RD
    Lancet; 1982 May; 1(8281):1109-11. PubMed ID: 6122901
    [No Abstract]   [Full Text] [Related]  

  • 9. [The cost of screening for breast and cervical cancer in France].
    Watt S
    Bull Cancer; 2003 Nov; 90(11):997-1004. PubMed ID: 14706904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group.
    Moss S
    J Med Screen; 1999; 6(3):144-8. PubMed ID: 10572845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammographic screening for breast cancer: An invited review of the benefits and costs.
    Greif JM
    Breast; 2010 Aug; 19(4):268-72. PubMed ID: 20371181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women.
    Taneja C; Edelsberg J; Weycker D; Guo A; Oster G; Weinreb J
    J Am Coll Radiol; 2009 Mar; 6(3):171-9. PubMed ID: 19248993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation of breast cancer screening: A review.
    Brown DW; French MT; Schweitzer ME; McGeary KA; McCoy CB; Ullmann SG
    Cancer Pract; 1999; 7(1):28-33. PubMed ID: 9893001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A question that will not go away: at what age should mammographic screening begin?
    Forrest AP; Alexander FE
    J Natl Cancer Inst; 1995 Aug; 87(16):1195-7. PubMed ID: 7563158
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mammography screening in Germany: how, when and why?].
    Bick U
    Rofo; 2006 Oct; 178(10):957-69. PubMed ID: 17021975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer screening; cost-effective in practice?
    De Koning HJ
    Eur J Radiol; 2000 Jan; 33(1):32-7. PubMed ID: 10674787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NHS breast screening programme. Money may be better spent on symptomatic women.
    Baum M
    BMJ; 1999 Feb; 318(7180):398. PubMed ID: 10075473
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for breast cancer.
    Forrest AP; Roberts MM
    Br J Hosp Med; 1980 Jan; 23(1):8. 13-4, 16 passim. PubMed ID: 6986935
    [No Abstract]   [Full Text] [Related]  

  • 19. An economic view of high compliance as a screening objective.
    Torgerson DJ; Donaldson C
    BMJ; 1994 Jan; 308(6921):117-9. PubMed ID: 8298385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population breast-cancer screening.
    Thornton H
    Lancet; 1995 Apr; 345(8953):855. PubMed ID: 7898239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.